Related Experiment Video

Updated: Jun 17, 2026

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice
05:07

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice

Published on: August 25, 2023

[Recent advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention]

Davide Capodanno1, Corrado Tamburino

  • 1Dipartimento di Cardiologia, Ospedale Ferrarotto, Università, Catania.

Recenti Progressi in Medicina
|January 14, 2010
PubMed

Insights

No-reflow, a failure to restore coronary blood flow after treatment, affects 5% to 50% of patients. This review covers current knowledge and future directions for diagnosing, preventing, and treating this complication.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • No-reflow is a complication of percutaneous coronary intervention (PCI).
  • It is defined as the failure to restore normal antegrade coronary flow despite successful treatment of the coronary obstruction.
  • The incidence varies widely (5%–50%) based on assessment methods and clinical context.

Purpose of the Study:

  • To review recent advances in understanding no-reflow.
  • To detail current knowledge on the diagnosis, prevention, and treatment of no-reflow.
  • To highlight future developments in managing this complication.

Main Methods:

  • Literature review of recent advances in no-reflow research.
  • Synthesis of current knowledge on diagnosis, prevention, and treatment strategies.
  • Exploration of emerging trends and future research directions.

Main Results:

  • No-reflow is a significant complication in PCI with a broad incidence range.
  • Understanding of the underlying mechanisms of no-reflow has advanced.
  • Current diagnostic, preventive, and therapeutic strategies are evolving.

Conclusions:

  • No-reflow remains a critical challenge in interventional cardiology.
  • Continued research is essential for improving patient outcomes.
  • Future developments will focus on enhanced diagnosis, targeted prevention, and effective treatments.

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...